Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks

Published on March 15, 2024 at 8:18 am by Fahad Saleem in Hedge Funds, Insider Trading, News

In this article, we will take a detailed look at Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks. For a quick overview of such stocks, read our article Billionaire Paul Tudor Jones and Insiders Love These 5 Stocks.

In an interview given to the Palm Beach Civic Association in January 2024, billionaire Paul Tudor Jones said that whatever happens in the US stock market in the next 12 to 24 months would largely depend on the fiscal situation and policy response of the next President of the country. Jones, who has a net worth of over $8 billion, said the stock market is not the manifestation of the economic fundamentals. Instead, according to Jones, markets represent people’s ideas and what they make of the economic situation. Paul Tudor Jones said that there’s a chance the stock market would be “here or lower” in the next five to ten years. However, the billionaire also said it’s possible that the markets would go higher from here if the next President of the US devises a better “policy response” next year.

Paul Tudor Jones Thinks AI Could Save Us From the Current “Mess”

Paul Tudor Jones also highlighted the concentration of stock market gains problem in the US and said last year most of the stock market gains came from the Magnificent Seven group of stocks which are pulling overall market returns through the roof. He repeatedly said that AI is “hugely” important when it comes to productivity gains and GDP growth in the US. He thinks AI could be the thing that would save us from the current economic “mess.”

“AI could be the knight on the horse that rides and saves us.”

What Worries Billionaire Paul Tudor Jones About AI?

But AI-related threats worry Paul Tudor Jones. He referred to a survey where close to 3,000 AI experts were asked whether they believe AI would end humanity. According to Jones, a whopping 58% of the experts said yes. The billionaire said US policymakers will have to decide how to tackle this problem. Jones believes AI is growing at an “unbridled pace” since there’s so much money to be made in the domain but the biggest problem for policymakers would be to balance the benefits and threats of AI to make it sustainable.

Jones said that he’s a macro trader who doesn’t trade a lot of individual stocks and instead focuses on trading “basket” of stocks like S&P 500, in addition to indexes in Europe and Japan. Nonetheless Jones’ latest portfolio shows he has big stakes in companies like NVIDIA Corp (NASDAQ: NVDA), Exxon Mobil Corp (NYSE:XOM) and Salesforce Inc (NYSE:CRM). In this article we will see which stocks in his portfolio are also seeing insider buying activity.

Methodology

For this article we first scanned Paul Tudor Jones’ Q4’2023 portfolio and picked 10 of these stocks which saw heavy insider buying activity over the past 12 months. But why is it important to keep tabs on hedge fund and insider activity? Hedge funds’ top 10 consensus stock picks outperformed the S&P 500 Index by more than 140 percentage points over the last 10 years (see the details here).

10. Wave Life Sciences Ltd (NASDAQ:WVE)

Paul Tudor Jones’ Stake: $184,729

RNA medicines company Wave Life Sciences Ltd. (NASDAQ:WVE) is one of the stocks in Paul Tudor Jones’ portfolio that saw insider buying over the past few months. RA CAPITAL MANAGEMENT, L.P., which has a director status at the company’s board, bought one million shares of the company on December 11, 2023, at $5.00 per share. Since then the stock has gained about 54%.

In its Q4 earnings call earlier this month, the company talked about future expectations and progress on its products:

“We’re advancing WAVE-006 in our ongoing RestorAATion clinical program. The program is comprised of two interconnected portions, RestorAATion-1 for healthy volunteers and RestorAATion-2 in AATD for patients who have the homozygous PiZZ mutation. In addition to generating key safety and PK data, RestorAATion-1 is designed to rapidly establish a dose level and regimen that’s expected to engage target. In the RestorAATion-2, we will be taking multiple assessments of serum M-AAT through the low, medium, and high dose cohorts, which will enable us to quickly detect the potential presence of wild-type healthy M-AAT protein in serum, representing achievement of proof of mechanism.

Remember, these easy patients have never made M-AAT protein. So, the presence of any M-AAT would demonstrate that WAVE-006 is successfully editing RNA. We are progressing well in RestorAATion-1. Dose escalation is ongoing. Pharmacokinetic data is as expected, and blinded safety data has been encouraging. We’re on track to initiate the RestorAATion-2 study and deliver proof of mechanism data from RestorAATion-2 in patients with AATD this year. Turning to DMD. This week, our team attended the 2024 MDA Clinical and Scientific Conference, where we showed posters on our clinical data from Part A, including the first evidence of myogenic stem cell or satellite cell uptake. Myogenic stem cells are the progenitor cells for new myoblast, and we’re not aware of any other clinical data for exon skippers or gene therapies that have been able to demonstrate myogenic stem cell uptake.

The DMD community is excited about these data and what they may mean for their boys. Our post has also highlighted our industry-leading mean 53% exon skipping, which was driven by muscle tissue concentrations of 42 micrograms per gram or 42,000 nanograms per gram, which is thousand-fold above what other exon skipping companies have reported. These data give us confidence in achieving best-in-class dystrophin protein expression in our ongoing potentially registrational phase 2 clinical trial, FORWARD-53. FORWARD-53 is an open label trial, which is currently evaluating 10 mg per kg doses of N531 administered every other week. The trial is powered to evaluate functional endogenous dystrophin expression after 24 and 48 weeks of treatment, which will be the trial’s primary endpoint.”

Read the entire earnings call transcript here.

9. Iovance Biotherapeutics Inc (NASDAQ:IOVA)

Paul Tudor Jones’ Stake: $269,493

Tudor Investment Corporation initiated a new stake in Iovance Biotherapeutics Inc (NASDAQ:IOVA) during the fourth quarter of 2023, buying $269,344 worth of company shares during the period.

On February 20, 2024, Wayne P. Rothbaum, a director at Iovance Biotherapeutics Inc (NASDAQ:IOVA) board, bought 5,000,000 shares of Iovance Biotherapeutics Inc (NASDAQ:IOVA) at $9.15 per share. The stock has gained about 22% since then.

Aristotle Large Cap Growth Strategy made the following comment about Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) in its Q3 2023 investor letter:

“We sold Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) following uncertainty which arose from the company canceling out of two investor events. Iovance is in the late stages of FDA review on their lead candidate Lifileucel in advanced melanoma. These cancellations could stem from issues with site inspections which tend to take place later in the review cycle. The company has not commented on why it canceled these investor events, and we do not think this bodes well for the prospects of a straightforward approval with a clean, positive label for the company.”

8. Aon PLC (NYSE:AON)

Paul Tudor Jones’ Stake: $38,144,573

Aon PLC (NYSE:AON) ranks ninth in our list of the stocks bought by Paul Tudor Jones as well as corporate insiders. Professional services and management consulting company Aon PLC (NYSE:AON) is among the top stock picks of Jones as his hedge fund had a $38.14 million stake in Aon PLC (NYSE:AON).

On February 7, 2024, Lester B Knight, a director at Aol plc, bought 50,000 shares of Aon PLC (NYSE:AON) at $301.97 per share. Since then the stock has gained about 6%.

In addition to AON, Jones is also bullish on NVIDIA Corp (NASDAQ: NVDA), Exxon Mobil Corp (NYSE:XOM) and Salesforce Inc (NYSE:CRM).

Polen Global Growth Strategy stated the following regarding Aon plc (NYSE:AON) in its fourth quarter 2023 investor letter:

“AON PLC’s (NYSE:AON) stock price underperformed this past quarter following the announcement of the company’s acquisition of NFP, a middle market insurance broker, for $13 billion. Though the deal complements Aon’s current business, it is expected to be dilutive to earnings in the near term, prompting a sell-off in the shares. We will continue to assess the merits of the NFP transaction, but it does not currently change our long-term view of Aon, which we view as a steady, durable, low-teens earnings compounder.”

7. Scholar Rock Holding Corp (NASDAQ:SRRK)

Paul Tudor Jones’ Stake: $475,490

Massachusetts-based biopharma company Scholar Rock Holding Corp (NASDAQ:SRRK) ranks seventh in our list of the stocks in Paul Tudor Jones’ portfolio that are also bought by corporate insiders.

Tudor Investment Corporation owns a $475,490 stake in Scholar Rock Holding Corp (NASDAQ:SRRK) as of the end of the fourth quarter of 2023.

On October 16, Srinivas Akkaraju, a director at Scholar Rock Holding Corp’s (NASDAQ:SRRK) board, loaded up on 2,189,781 shares of Scholar Rock Holding Corp (NASDAQ:SRRK) at $6.85 per share. Scholar Rock shares have skyrocketed by about 98% since the date of this insider buying transaction.

In addition to SRRK, hedge funds are also buying NVIDIA Corp (NASDAQ: NVDA), Exxon Mobil Corp (NYSE:XOM) and Salesforce Inc (NYSE:CRM).

6. Asana Inc (NYSE:ASAN)

Paul Tudor Jones’ Stake: $3,677,256

Paul Tudor Jones, via his hedge fund Tudor Investment Corporation, increased his stake in project management software company Asana Inc (NYSE:ASAN) by over 200% during the fourth quarter of 2023, ending the period with a $3.7 million stake in Asana Inc (NYSE:ASAN).

As of the end of the fourth quarter of 2023, 24 hedge funds tracked by Insider Monkey had stakes in Asana Inc (NYSE:ASAN). Asana Inc (NYSE:ASAN) kept seeing heavy insider buying activity throughout 2023. On November 1, Asana Inc’s (NYSE:ASAN) CEO Dustin Moskovitz loaded up on 237,015 shares of Asana Inc (NYSE:ASAN) at $17.50 per share. Since then the stock has declined by about 9% through March 13.

Click to continue reading and see Billionaire Paul Tudor Jones and Insiders Love These 5 Stocks.

Suggested Articles:

Disclosure. None. Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks was initially published on Insider Monkey.

Headline NYSE:AON NYSE:ASAN NASDAQ:WVE NASDAQ:SRRK Show more...

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Published on October 30, 2024 at by Inan Dogan, PhD

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

A New Dawn is Coming to U.S. Stocks

Published on November 16, 2024 at by Insider Monkey Staff

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…

Insider Monkey Ads

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Log In

Sign Up